Revolutionizing Breast Cancer Diagnosis with Innovations in Biopsy TechniquesPosted by snehal shaha on February 15th, 2023 Introduction to the Breast Biopsy Market A breast biopsy is a medical procedure in which a sample of suspicious tissue is taken from the breast to determine if it is cancerous. It is a minimally invasive procedure and is usually done under local anaesthetic. The biopsy is typically performed in a doctor's office or hospital. The market for breast biopsy is growing due to the increasing awareness about breast cancer, technological advancements, and increasing government initiatives for the early detection of breast cancer. Global Breast Biopsy Market Overview The global Breast biopsy market is projected to reach USD 1,094 million by 2025, at a CAGR of 8.6%. Breast biopsy is a procedure used to diagnose breast cancer or other abnormalities. It is a procedure used to remove a sample of tissue from the breast, which is then examined under the microscope by a pathologist to determine the presence of breast cancer or other abnormalities. Increase in prevalence of breast cancer and rising awareness among women regarding breast cancer are the major factors driving the growth of the global breast biopsy market. However, lack of skilled professionals and side effects associated with biopsy procedures are anticipated to hamper the market growth. On the other hand, technological advancements in biopsy procedures are expected to provide lucrative opportunities for the market growth. Download PDF Brochure: Drivers of the Breast Biopsy Market
Opportunities of Breast Biopsy Market
Regional Breast Biopsy Market Analysis The healthcare infrastructure in emerging economies such as China, India, and South Korea is evolving at a rapid pace, leading to major investments in advanced systems (including liquid breast biopsy, and vacuum-assisted biopsy instruments, among others) by hospitals and breast care centers. This factor is driving the growth of Asia pacific breast biopsy market. Moreover, rising prevalence of breast cancer, growing number of awareness programs for the early detection of breast cancer, and the high government spending on breast cancer research studies are the other major factors driving the growth of the breast biopsy market in Asia Pacific. Major Players in the Breast Biopsy Market Hologic, Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), QIAGEN (Netherlands), and Illumina, Inc. (US) are the top five players in the global breast biopsy market. Other prominent players operating in this market include Merit Medical Systems (US), Medtronic (Ireland), IZI Medical Products (US), Argon Medical (US), STERYLAB S.r.l. (Italy), Scion Medical Technologies, LLC (China), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), and Thermo Fisher Scientific, Inc. (US), among others. Recent Developments of Breast Biopsy Market
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=189011805 Conclusion: Factors such as the increasing prevalence of breast cancer, technological advancements in breast biopsy, and the rising awareness of breast cancer are driving the growth of the market. Moreover, the increasing adoption of minimally invasive procedures, government initiatives to promote the early detection of breast cancer, and the availability of reimbursement for breast biopsy procedures are also propelling the market growth. Additionally, the rising number of medical tourism and the increasing disposable income of people in developing countries are expected to contribute to the growth of the market. Like it? Share it!More by this author |